Detalhe da pesquisa
1.
Low incidence of cardiotoxicity in patients with non-Hodgkin lymphoma receiving EPOCH after prior anthracycline exposure.
Eur J Haematol
; 111(1): 96-102, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-36971022
2.
Outpatient clinical pharmacy practice in the face of COVID-19 at a cancer center in New York City.
J Oncol Pharm Pract
; 27(2): 389-394, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33459159
3.
Successful implementation of outpatient R ± DHAX (rituximab, dexamethasone, oxaliplatin, cytarabine) for select patients with lymphoma: a single-center experience.
Leuk Lymphoma
; 63(4): 876-884, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34784853
4.
IVAC With or Without Rituximab for Relapsed or Refractory B-Cell Non-Hodgkin Lymphomas: Real-World Experience in the Modern Era.
Clin Lymphoma Myeloma Leuk
; 21(12): 873-878, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34413005